Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
23
BIOX Quote, Financials, Valuation and Earnings
Last price:
$1.33
Seasonality move
:
-2.13%
Day range:
$1.31 - $1.36
52-week range:
$1.20 - $7.44
Dividend yield:
0%
P/E ratio:
312.90x
P/S ratio:
0.26x
P/B ratio:
0.34x
Volume:
140K
Avg. volume:
420.8K
1-year change:
-79.15%
Market cap:
$83.8M
Revenue:
$333.3M
EPS (TTM):
-$0.92
Analysts' Opinion
-
Consensus RatingBioceres Crop Solutions Corp. has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $2.25, Bioceres Crop Solutions Corp. has an estimated upside of 70.46% from its current price of $1.32.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.25 representing 100% downside risk from its current price of $1.32.
Fair Value
-
According to the consensus of 3 analysts, Bioceres Crop Solutions Corp. has 70.46% upside to fair value with a price target of $2.25 per share.
BIOX vs. S&P 500
-
Over the past 5 trading days, Bioceres Crop Solutions Corp. has underperformed the S&P 500 by -6.34% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Bioceres Crop Solutions Corp. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Bioceres Crop Solutions Corp. revenues have been falling on a year-over-year basis for 5 quarters in a row. In the most recent quarter Bioceres Crop Solutions Corp. reported revenues of $77.4M.
Earnings Growth
-
Bioceres Crop Solutions Corp. earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Bioceres Crop Solutions Corp. reported earnings per share of -$0.12.
Enterprise value:
364.6M
EV / Invested capital:
--
Price / LTM sales:
0.26x
EV / EBIT:
31.46x
EV / Revenue:
1.15x
PEG ratio (5yr expected):
--
EV / Free cash flow:
12.88x
Price / Operating cash flow:
2.92x
Enterprise value / EBITDA:
18.67x
Gross Profit (TTM):
$113.1M
Return On Assets:
-7.59%
Net Income Margin (TTM):
-18.89%
Return On Equity:
-19.09%
Return On Invested Capital:
-10.08%
Operating Margin:
8.79%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $408.8M | $441.3M | $318.2M | $92.6M | $77.4M | |
| Gross Profit | $160.9M | $160.7M | $113.1M | $32.5M | $31.7M | |
| Operating Income | $43.9M | $40.6M | -$3.2M | $2.4M | $6.8M | |
| EBITDA | $63.6M | $62.5M | $19.5M | $7.9M | $12.6M | |
| Diluted EPS | $0.21 | $0.01 | -$0.92 | -$0.10 | -$0.12 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $263.7M | $363M | $395.4M | $377.1M | $283.2M | |
| Total Assets | $452.3M | $785.3M | $819.7M | $827.3M | $734.9M | |
| Current Liabilities | $202.4M | $243.3M | $311.7M | $295.9M | $299.7M | |
| Total Liabilities | $355.2M | $479.7M | $496.4M | $490.5M | $455.8M | |
| Total Equity | $97.1M | $305.5M | $323.3M | $336.7M | $279M | |
| Total Debt | $181.4M | $206.6M | $178.3M | $190.6M | $103.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $30.2M | $7.1M | $41.1M | $348.3K | $10.5M | |
| Cash From Investing | -$37.4M | -$19.8M | -$7.7M | $271.7K | -$1.3M | |
| Cash From Financing | -$14.7M | $23.1M | -$42.6M | -$14M | -$24.9M | |
| Free Cash Flow | $6.5M | -$12.8M | $28.3M | -$2.8M | $9.2M | |
BIOX
Sector
Market Cap
$83.8M
$22.5M
Price % of 52-Week High
17.75%
73.33%
Dividend Yield
0%
0%
Shareholder Yield
3.83%
-2.68%
1-Year Price Total Return
-79.15%
13.68%
Beta (5-Year)
0.452
0.619
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.42
200-day SMA
Sell
Level
$3.17
Bollinger Bands (100)
Sell
Level
1.37 - 2.57
Chaikin Money Flow
Sell
Level
-10.7M
20-day SMA
Sell
Level
$1.53
Relative Strength Index (RSI14)
Sell
Level
35.40
ADX Line
Sell
Level
13.77
Williams %R
Buy
Level
-97.4359
50-day SMA
Sell
Level
$1.67
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-68
On Balance Volume
Sell
Level
-3.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.5922)
Sell
CA Score
(Annual)
Level (-1.046)
Buy
Beneish M-Score
(Annual)
Level (-3.1218)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (1.3807)
Sell
Piotroski F Score
(Annual)
Level (3)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (5)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Bioceres Crop Solutions Corp. engages in the provision of crop productivity solutions. The firm includes seeds, seed traits, seed treatments, biologicals, high-value adjuvants and fertilizers. It operates through the following segments: Seed and Integrated Products, Crop Protection, and Crop Nutrition. The Seed and Integrated Products segment deals with the development and commercialization of integrated products that combine three complementary components biotechnological events, germplasm and seed treatments in order to increase crop productivity and create value for customers. The Crop Protection segment develops and produces adjuvants, insecticides and fungicides. The Crop Nutrition segment focuses on the development, production and commercialization of inoculants that allow the biological fixation of nitrogen in the crops and of fertilizers including bio fertilizers and micro granulated fertilizers that increases the productivity and yield of the crops. The company was founded on November 14, 2017 and is headquartered in Rosario, Argentina.
Stock Forecast FAQ
In the current month, BIOX has received 0 Buy ratings 3 Hold ratings, and 0 Sell ratings. The BIOX average analyst price target in the past 3 months is $2.25.
-
Where Will Bioceres Crop Solutions Corp. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Bioceres Crop Solutions Corp. share price will rise to $2.25 per share over the next 12 months.
-
What Do Analysts Say About Bioceres Crop Solutions Corp.?
Analysts are divided on their view about Bioceres Crop Solutions Corp. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Bioceres Crop Solutions Corp. is a Sell and believe this share price will drop from its current level to $2.25.
-
What Is Bioceres Crop Solutions Corp.'s Price Target?
The price target for Bioceres Crop Solutions Corp. over the next 1-year time period is forecast to be $2.25 according to 3 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is BIOX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Bioceres Crop Solutions Corp. is a Hold. 3 of 3 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of BIOX?
You can purchase shares of Bioceres Crop Solutions Corp. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Bioceres Crop Solutions Corp. shares.
-
What Is The Bioceres Crop Solutions Corp. Share Price Today?
Bioceres Crop Solutions Corp. was last trading at $1.33 per share. This represents the most recent stock quote for Bioceres Crop Solutions Corp.. Yesterday, Bioceres Crop Solutions Corp. closed at $1.32 per share.
-
How To Buy Bioceres Crop Solutions Corp. Stock Online?
In order to purchase Bioceres Crop Solutions Corp. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get BIOX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BIOX
Sector
P/E ratio
312.90x
19.48x
PEG ratio
--
-0.02x
P/B ratio
0.34x
1.73x
Price / LTM sales
0.26x
1.56x
Growth Metrics
BIOX
Sector
Revenue growth
-16.4%
2.23%
Earnings growth
-14.02%
--
Revenue (5-year growth)
14.1%
3.12%
Earnings forecast
-$0.09
$0.02
Profitability
BIOX
Sector
Profitability FY 2025
$113.9M
--
Return on invested capital
-10.08%
-8.83%
Return on assets
-7.59%
-9.87%
Return on equity
-19.09%
-9.61%
Earnings Date
Last Earnings Date
Nov
12
Next Earnings Date
Feb
11
Estimated Next Earnings Date
Feb
11
Balance Sheet
BIOX
Sector
Total cash
$16.6M
$2.6M
Short term investments
$11.7M
$229.2K
Total assets
$763.6M
$16.9M
Long term debt
$103.2M
--
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
72
GLTO alert for Dec 27
Galecto, Inc. [GLTO] is up 16.92% over the past day.
Sell
20
SMX alert for Dec 27
SMX (Security Matters) Plc [SMX] is down 15.76% over the past day.
Sell
11
CDNAF alert for Dec 27
Canadian Tire Corp. Ltd. [CDNAF] is down 10% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
